232 related articles for article (PubMed ID: 9233646)
1. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice.
Peters M; Odenthal M; Schirmacher P; Blessing M; Fattori E; Ciliberto G; Meyer zum Buschenfelde KH; Rose-John S
J Immunol; 1997 Aug; 159(3):1474-81. PubMed ID: 9233646
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
[TBL] [Abstract][Full Text] [Related]
3. Hepatic regeneration induces transient acute phase reaction: systemic elevation of acute phase reactants and soluble cytokine receptors.
Fulop AK; Pocsik E; Brozik M; Karabelyos C; Kiss A; Novak I; Szalai C; Dobozy O; Falus A
Cell Biol Int; 2001; 25(7):585-92. PubMed ID: 11448096
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes.
Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA
Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver.
Maione D; Di Carlo E; Li W; Musiani P; Modesti A; Peters M; Rose-John S; Della Rocca C; Tripodi M; Lazzaro D; Taub R; Savino R; Ciliberto G
EMBO J; 1998 Oct; 17(19):5588-97. PubMed ID: 9755159
[TBL] [Abstract][Full Text] [Related]
6. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field.
Hisano S; Sakamoto K; Ishiko T; Kamohara H; Ogawa M
Cytokine; 1997 Jun; 9(6):447-52. PubMed ID: 9199879
[TBL] [Abstract][Full Text] [Related]
7. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.
Peters M; Jacobs S; Ehlers M; Vollmer P; Müllberg J; Wolf E; Brem G; Meyer zum Büschenfelde KH; Rose-John S
J Exp Med; 1996 Apr; 183(4):1399-406. PubMed ID: 8666898
[TBL] [Abstract][Full Text] [Related]
8. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin 6 receptor is biologically active in vivo.
Mackiewicz A; Wiznerowicz M; Roeb E; Karczewska A; Nowak J; Heinrich PC; Rose-John S
Cytokine; 1995 Feb; 7(2):142-9. PubMed ID: 7780033
[TBL] [Abstract][Full Text] [Related]
10. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
12. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.
Oh JW; Revel M; Chebath J
Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669
[TBL] [Abstract][Full Text] [Related]
13. Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor.
Thibault V; Terlain B; Gauldie J
J Interferon Cytokine Res; 1996 Nov; 16(11):973-81. PubMed ID: 8938575
[TBL] [Abstract][Full Text] [Related]
14. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins.
Mackiewicz A; Schooltink H; Heinrich PC; Rose-John S
J Immunol; 1992 Sep; 149(6):2021-7. PubMed ID: 1381393
[TBL] [Abstract][Full Text] [Related]
15. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes.
Paysant J; Blanqué R; Vasse M; Soria C; Soria J; Gardner CR
Cytokine; 2000 Jun; 12(6):774-9. PubMed ID: 10843763
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
Igaz P; Tóth S; Rose-John S; Madurka I; Fejér G; Szalai C; Falus A
Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935
[TBL] [Abstract][Full Text] [Related]
18. Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells.
Oh JW; Katz A; Harroch S; Eisenbach L; Revel M; Chebath J
Oncogene; 1997 Jul; 15(5):569-77. PubMed ID: 9247310
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J
Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390
[TBL] [Abstract][Full Text] [Related]
20. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
Yoshida S; Harada T; Iwabe T; Taniguchi F; Mitsunari M; Yamauchi N; Deura I; Horie S; Terakawa N
Hum Reprod; 2004 Aug; 19(8):1821-5. PubMed ID: 15166129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]